Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T22:12:57.226Z.
Calculation as of: 2026-10-06T22:12:57.226Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b70623a88433601380a910b4a26e46749c34683655cbd5a24a177d079a9c6739
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Onconetix, Inc.
Market Cap
$2.37M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| Onconetix, Inc. (ONCO) | $2.37M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | N/A |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
